InterVenn BioSciences leverages mass spectrometry-based glycoproteomics and artificial intelligence to enable biomarker discovery and disease diagnosis.

Connect:
  

Founders: 
Aldo Carrascoso
Lieza Danan-Leon
Carlito Lebrilla
Carolyn Bertozzi